This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Wednesday's Winners & Losers: Nortel Networks

Shares of Nortel Networks (NT) gained $1.10, or 13.6%, to $9.21 after The Wall Street Journal reported that the company is focusing its research and development effort on a new broadband technology called LTE (Long-term evolution) and away from WiMax.

PDL Biopharma (PDLI - Get Report) was one of the very few stocks on the biotech indices that registered a gain. The stock added 48 cents, or 4.7%, to $10.74.

Central Garden & Pet (CENT - Get Report), a Walnut Creek, Calif.-based marketer and producer of lawn and garden products as well as pet supplies, tumbled 36% to $4.44. The company said late Tuesday that high grain costs may cause fiscal 2008 profits to fall short of prior-year results. Management had said on a May 7 conference call that it expected modest year-over year improvements in financial results.

GlaxoSmithKline (GSK - Get Report) said Wednesday it is eliminating 350 jobs, or roughly 2% of its research and development staff, as part of a previously announced restructuring plan to increase productivity. Shares were down 33 cents, or 0.8%, at $41.39.

Memory chips maker Qimonda (QI) added 24 cents, or 5.9%, to $4.30 after the company said it has completed a deal to form a technology partnership to jointly develop memory chips with Elphida Memory.

TGC Industries (TGE), out of Plano, Texas, which provides seismic data to oil and natural gas companies, climbed $1.14, or 16%, to $8.37. The company reported that it expects its business backlog to increase substantially from the $46 million it reported at the end of the first quarter.
This article was written by a staff member of

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CENT $16.77 5.54%
GSK $39.96 1.16%
PDLI $5.23 2.35%
TGE $3.70 5.11%
AAPL $110.78 0.36%


Chart of I:DJI
DOW 16,776.43 +304.06 1.85%
S&P 500 1,987.05 +35.69 1.83%
NASDAQ 4,781.2640 +73.4890 1.56%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs